- Home
- LEGN vs GTLB Comparison
LEGN vs GTLB Comparison
Compare LEGN & GTLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LEGN | GTLB |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 6.6B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | LEGN | GTLB |
|---|---|---|
| Price | $21.90 | $38.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 13 | 27 |
| Target Price | ★ $69.58 | $54.50 |
| AVG Volume (30 Days) | 2.6M | ★ 5.6M |
| Earning Date | 11-12-2025 | 12-02-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $909,045,000.00 | $906,253,000.00 |
| Revenue This Year | $68.83 | $26.43 |
| Revenue Next Year | $51.27 | $20.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 74.75 | 27.36 |
| 52 Week Low | $21.19 | $35.81 |
| 52 Week High | $45.30 | $74.18 |
Technical Indicators
Market Signals| Indicator | LEGN | GTLB |
|---|---|---|
| Relative Strength Index (RSI) | 24.20 | 37.81 |
| Support Level | $21.19 | $37.54 |
| Resistance Level | $28.97 | $39.00 |
| Average True Range (ATR) | 1.27 | 1.54 |
| MACD | -0.27 | 0.05 |
| Stochastic Oscillator | 7.33 | 27.81 |
Price Performance
Historical ComparisonAbout LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About GTLB GitLab Inc.
GitLab Inc operates on an all-remote model. GitLab, a complete DevSecOps platform delivered as a single application. It operates in two competitive landscapes: DevOps point solutions and DevOps platforms. In terms of point solutions that are stitched together, GitLab's offering is substantially different in that it is one platform, one codebase, one interface, and a unified data model that spans the entire DevSecOps lifecycle. DevOps platforms, the principal competitor is Microsoft Corporation following their acquisition of GitHub. GitLab is offered on both self-managed and software-as-a-service (SaaS) models. It is located in the United States, Europe, and Asia Pacific. It focused on accelerating innovation and broadening the distribution of its platform to companies across the world.